WallStreetZenWallStreetZen

NASDAQ: XAIR
Beyond Air Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for XAIR

Based on 4 analysts offering 12 month price targets for Beyond Air Inc.
Min Forecast
$10.00+332.9%
Avg Forecast
$12.25+430.3%
Max Forecast
$15.00+549.35%

Should I buy or sell XAIR stock?

Based on 4 analysts offering ratings for Beyond Air Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XAIR stock forecasts and price targets.

XAIR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Bottom 8%
8
Strong BuyInitiates Coverage On$10.00+332.90%2023-07-28
Truist Securities
Bottom 14%
14
Strong BuyMaintains$14.00+506.06%2023-07-21
Oppenheimer
Bottom 11%
11
BuyMaintains$10.00+332.90%2023-06-23
BTIG
Top 15%
86
Strong BuyInitiates Coverage On$15.00+549.35%2023-06-15

1 of 1

Forecast return on equity

Is XAIR forecast to generate an efficient return?
Company
117.17%
Industry
0%
Market
28.75%
XAIR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XAIR forecast to generate an efficient return on assets?
Company
56.87%
Industry
0%
XAIR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XAIR revenue growth forecast

How is XAIR forecast to perform vs Medical Devices companies and vs the US market?
Company
1,422.79%
Industry
6.58%
Market
8.15%
XAIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XAIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XAIR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
XAIR$2.31$12.25+430.30%Strong Buy
RBOT$0.59$9.00+1,422.84%Strong Buy
ASXC$0.27$1.50+455.56%Strong Buy
MGRM$2.60N/AN/A
CATX$0.27$1.20+337.96%Buy
View Top Medical Device Stocks

Beyond Air Stock Forecast FAQ

Is Beyond Air Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: XAIR) stock is to Strong Buy XAIR stock.

Out of 4 analysts, 3 (75%) are recommending XAIR as a Strong Buy, 1 (25%) are recommending XAIR as a Buy, 0 (0%) are recommending XAIR as a Hold, 0 (0%) are recommending XAIR as a Sell, and 0 (0%) are recommending XAIR as a Strong Sell.

If you're new to stock investing, here's how to buy Beyond Air stock.

What is XAIR's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: XAIR) forecast ROE is 117.17%, which is considered strong.

What is XAIR's Price Target?

According to 4 Wall Street analysts that have issued a 1 year XAIR price target, the average XAIR price target is $12.25, with the highest XAIR stock price forecast at $15.00 and the lowest XAIR stock price forecast at $10.00.

On average, Wall Street analysts predict that Beyond Air's share price could reach $12.25 by Jul 28, 2024. The average Beyond Air stock price prediction forecasts a potential upside of 430.3% from the current XAIR share price of $2.31.

What is XAIR's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: XAIR) forecast ROA is 56.87%, which is higher than the forecast US Medical Devices industry average of 0%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.